###### Strengths and limitations of this study

-   It presents results on all major indirect costs categories such as absenteeism, presenteeism, disability, premature mortality and worker compensation from 50 studies and discusses the issue of causality.

-   It assesses comprehensively the monetary value of the indirect costs of overweight and obesity which allows (inter-)national comparisons among all indirect cost categories. This in turn gives policymakers and intervention developers the basis they need to make informed decisions on (re-)allocating resources to address those cost categories with the highest burden.

-   It applies an extensive quality assessment of approaches, methods and estimates of indirect costs of overweight and obesity which helps to better understand the utility and applicability of included cost-of-illness studies.

-   Due to diverging body mass index groups and indirect cost categories among the studies included, a graphical comparison of the average costs per person or per country of each study was conducted (instead of a meta-analysis).

-   Publication bias (whereby positive studies are more likely to be published than negative ones) and selection bias (exclusion of studies written in languages other than English or German) limit the generalisability of the findings of this review.

Introduction {#s1}
============

The obesity epidemic has become a global public health concern.[@R1] The rising rates of overweight and obesity are accompanied in adulthood by a higher risk of type 2 diabetes, hypertension, coronary heart disease and stroke,[@R2] which cause substantial healthcare costs. In 2008, the estimated annual medical cost of obesity in USA was US\$147 billion due to 42% higher medical spending per capita.[@R3] USA has significantly high obesity costs and other countries also struggle with substantial overweight-related and obesity-related medical costs; Germany, for example, had costs of \$9.2 billion in 2008.[@R4] The rising prevalence of overweight and obesity is also related to indirect costs resulting from morbidity and mortality.[@R5] Indirect costs are defined as the losses from reduced work productivity due to short-term and long-term inability to work. In particular, obesity is associated with an increased risk of temporary work loss such as sick leave (absenteeism) and reduced productivity while being present at work (presenteeism). It is also associated with permanent work loss, which includes disability pension and premature death.[@R5] Indeed, recent reviews have found strong evidence that temporary and permanent work loss attributable to obesity result in a substantial burden for national health and insurance pension systems.[@R8]

While a number of systematic reviews have analysed lost productivity of overweight and obesity among workers, their range is relatively narrow. For example, several do not include the monetary value of the indirect costs,[@R5] while others focus only on the combined direct and indirect costs of obesity.[@R10] Similarly, a few limit their range by concentrating on specific countries[@R9] or specific cost categories such as absenteeism and disability.[@R5] Indeed, only one review provides a more extensive overview of the economic consequences of absenteeism, presenteeism, disability, premature mortality and worker compensation costs.[@R13] Yet even this review does not comprehensively assess the monetary value of indirect costs or provide a quality assessment of the included studies. However, it does identify several weaknesses among the included studies (eg, paucity of both longitudinal studies and presenteeism assessments as well as the need for monetary values of missed work).

Our review addresses the shortcomings of previous systematic reviews and includes studies which acknowledge the research gaps noted by Trogdon *et al*.[@R13] With its broad range, our review is the only international review that presents an extensive comparison of the monetary consequences of all indirect cost categories. We systematically review and critically assess both the current evidence for each type of indirect costs and the methodology and research design used. In addition, we address briefly the question of causality between obesity and costs.

Methods {#s2}
=======

This review was conducted according to the Centre for Reviews and Dissemination guidance for undertaking reviews in healthcare.[@R14]

Search strategy {#s2a}
---------------

In cooperation with a Cochrane expert from the University Library of Heidelberg, we developed a search strategy to identify all published studies on the indirect costs of overweight and obesity. A keyword search was carried out using the following electronic databases and study registers from inception to June 2017: PubMed, Cochrane Library, Web of Science Core Collection, PsychInfo, Cinahl, EconLit and ClinicalTrial.gov. The search terms and the search strategy are outlined in online [supplementary supporting information 1 and 2](#SP1){ref-type="supplementary-material"}.
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Inclusion and exclusion criteria {#s2b}
--------------------------------

Studies were included if they contained a monetary estimate of the indirect costs of overweight and obesity. Indirect costs were defined as costs of overweight and obesity on labour market outcomes (absenteeism, presenteeism, short-term and long-term disability, premature death). We excluded studies, which were published in languages other than English or German, located in a developing country due to substantial differences in labour markets or connected to other illnesses. We decided to exclude studies published before 2000 because of the rising prevalence of overweight and obesity in the last few decades,[@R1] which led to significant increases of macroeconomic costs. Instead, we placed our focus on recent results, which have not been covered in previous systematic reviews. Furthermore, only peer-reviewed studies with a full-text available were included.

Study selection procedure and data extraction {#s2c}
---------------------------------------------

Two reviewers independently applied the inclusion and exclusion criteria. All studies underwent a title and abstract screening, and potentially relevant citations were additionally checked in a full-text screening. Disagreements were resolved through discussion and reasons for exclusion recorded. Finally, 50 studies were identified as eligible. The PRISMA diagram ([figure 1](#F1){ref-type="fig"}) illustrates the study selection process. Data extracted included study design, target population, time horizon, effect groups, cost category and measurement and background characteristics such as authors and years of study and publication. Costs were first inflated to 2016 rates using country-specific gross domestic product inflators from the Organisation for Economic Co-Operation and Development (<http://stats.oecd.org>) and then converted to December 2016 US dollars. The third step was to multiply them with their respective power purchasing parity (PPP) value to achieve a comparable overview. If the year of costing was missing, the authors of the cost-of-illness (COI) study were contacted by email.

![PRISMA flow diagram.](bmjopen-2016-014632f01){#F1}

Quality assessment {#s2d}
------------------

In the absence of a checklist for COI studies, we conducted a quality assessment by adapting the checklist by Stuhldreher and co-authors, which evaluates the quality of COI studies.[@R15] We assessed the following items: scope, general economic characteristics, calculation of costs, study design and analyses and presentation of results (see online [supplementary supporting information 3](#SP1){ref-type="supplementary-material"}). Two authors performed the assessment independently. All discrepancies and uncertainties were resolved through consensus.

Results {#s3}
=======

We identified 3626 articles from the database searches. Title and abstract screening reduced these further to 281 studies, which were retrieved in full text. Reviewing reference lists of relevant papers, studies and systematic reviews added four potentially relevant studies ([figure 1](#F1){ref-type="fig"}). Following full-text review, we excluded 231 of these studies, leaving 50 studies to be included in the review.

General characteristics of the studies {#s3a}
--------------------------------------

There was a wide variety among the included studies in terms of costs, target population and methodology. Online [supplementary supporting information 4](#SP1){ref-type="supplementary-material"} shows the sample, methodology, quality and results of the studies. Most studies were conducted in USA (27), followed by Germany (8), Canada (5), Australia (2), Sweden (2), Finland (1), Korea (1), New Zealand (1) and the Netherlands (1). Two studies were multicountry (one covering Ireland and Northern Ireland; the other covering France, Germany, Italy, Spain and UK). For cost estimations, a microeconomic or a macroeconomic approach was applied. While the macroeconomic approach captured the national economic loss of resources measured as national cost, the microeconomic approach measured indirect costs that occur per capita or per employee. More specifically, most studies assessed the costs of absenteeism, presenteeism, short-term and long-term disability and premature death. Only five[@R16] included insurance claims, such as indemnity claims, workers' compensation and other microeconomic costs related to recruitment, training, traffic, nursing or injuries. The majority of the studies included the costs of more than one of these cost categories.

Both the human capital approach (HCA) and the friction cost method (FCM) were used to calculate productivity losses. The HCA estimates costs based on the lost productivity of one individual, for example, the entire working time lost due to early retirement. The FCM only estimates the value of productivity lost until the employee is replaced. For example, if a worker goes into early retirement, the FCM would only count the period of working time lost until the worker is replaced.[@R19]

The effect measure was exclusively the body mass index (BMI). BMI cut-off points were based on standard WHO recommendations (overweight: 25.0≤BMI ≤29.9, class I obesity: 30.0≤BMI ≤ 34.9, class II obesity: 35.0≤BMI ≤39.9 and class III obesity: BMI≥40.0), with the exception of seven studies.[@R17] Few studies estimated indirect costs due to obesity-related comorbidities.[@R20] Some controlled for physical and psychological comorbidities in regression analyses[@R35] or created subgroups for the costs of additional, related diseases.[@R18]

Online [supplementary supporting information 4](#SP1){ref-type="supplementary-material"} displays the search results grouped by methodology into cross-sectional, longitudinal, population attributable risk and modelling studies. The majority were cross-sectional studies, which focused on annual per capita costs by assessing the overweight and obesity prevalence at a specific point in time. Longitudinal studies evaluated excess weight over a timespan of 4[@R44] to 38 years.[@R21] The attributable risk studies applied the population attributable fraction (PAF) method to estimate national costs. Only one study modelled the future costs of overweight and obesity based on disease prevalence among teenagers.[@R45] Eight studies were categorised separately as 'other studies', which were not as representative. This category includes one intervention analysis[@R34] and studies with non-representative samples, such as bariatric surgery eligible patients,[@R24] military participants,[@R35] parents of children with overweight or obesity[@R22] and hospital staff working with patients with obesity.[@R26]

Quality assessment {#s3b}
------------------

The quality of the included studies was quite diverse (see online [supplementary supporting information 3](#SP1){ref-type="supplementary-material"}). Overall, the majority of studies met 75% of quality criteria. Three studies met all criteria.[@R16] Walden *et al* received the lowest quality score. This study focused primarily on the prevention of injuries rather than on the costs of excess weight and thus did not include information on discounting, SD and cost perspective and valuation.[@R26]

Criteria regarding introduction, discussion and conclusion were mostly fulfilled. Quality was lacking in the categories 'calculation of costs', 'presentation of results' and 'study design and analysis'. Fourteen studies did not state from what perspective they calculated the costs and only included one cost category.[@R17] Study design and analysis were not fulfilled as over half of the studies did not report a sensitivity analysis and lacked information on the proportion of missing data or the imputation method. Furthermore, sample sizes and demographics were not always presented and only 29 studies provided SD or CIs of their results.

Microeconomic findings {#s3c}
----------------------

The cross-sectional and longitudinal studies mostly focused on the per capita or per employee indirect costs of overweight and obesity. [Figure 2](#F2){ref-type="fig"} displays excess cost (defined as the additional costs of overweight and obesity compared with normal weight) by weight category due to absenteeism, presenteeism and disability. All microeconomic and macroeconomic results in this review are presented in US\$PPP and estimate the annual indirect costs unless stated otherwise. One study[@R21] presented lifetime costs of overweight and another calculated the costs for a 10-year period.[@R39] One cost analysis study did not focus on productivity loss but analysed the injury costs among hospital staff attributable to heavy patients.[@R26] As shown in [figure 2](#F2){ref-type="fig"}, the costs for absenteeism range from −\$200[@R31] to \$1724[@R30] for overweight and from \$108[@R43] to \$1857[@R30] for obesity. While this shows that obesity is constantly associated with productivity costs, it also displays the divergence of the results. We will present the results for each cost category in detail in the following section.

![Microeconomic excess cost of overweight and obesity.^+^Adapted productivity losses per person,[@R51] with no information on costs of normal weight. \*Adapted indemnity claims cost per 100 full-time equivalents 1997--2004,[@R20] with no information on costs of normal weight. Excess per capita costs are displayed for each cost category for overweight, obesity and excess weight. Mean costs were estimated for studies which only had sex or obesity-grade specific costs available. If not available, excess costs were calculated by subtracting the cost of normal weight from overweight or obesity costs. The figure shows that the costs of obesity are significantly higher than those of overweight alone and those of overweight and obesity combined. Interestingly, the cost of overweight is not necessarily higher than the cost of healthy weight. Absenteeism and presenteeism were considerably higher and more commonly assessed than disability and premature death.](bmjopen-2016-014632f02){#F2}

### Absenteeism {#s3c1}

Defined as time away from work due to overweight and obesity, absenteeism was probably due to ease of measurement, the most common measure of indirect costs. The majority of studies (39 out of the 50 included ones) assessed the annual costs of short-term sick leave from work by comparing sick leave days of employees with normal weight with sick leave days of employees with overweight and obesity. The excess costs of overweight were estimated to be between \$54[@R51] and \$161[@R31] and the obesity-related costs between \$89[@R42] and \$1586.[@R53] The suggestions of Durden *et al* were significantly higher for both overweight (\$1738) and obesity (\$1857).[@R30] By contrast, other studies did not use an excess-cost approach but calculated the total yearly expenses due to absenteeism for normal, overweight and obesity samples. The cost for overweight ranged from \$29 to \$5132[@R23] and \$57 to \$6759 for obesity per person.[@R18]

In one study, the costs associated with healthy weight (\$294) were higher than overweight (\$94) but lower than the costs for obesity (\$402).[@R43] Three studies assessed the costs for men and women separately. For women with obesity, the cost was between \$170 and \$1391, which was higher than the cost for men with obesity (\$89--\$1130).[@R31] Gussenhoven *et al* and Kyröläinen *et al* estimated the costs of excess weight (BMI \>25) between \$915[@R47] and \$4307.[@R34] Another study assessed the relationship between children with overweight or obesity and parental work absence and found that while the cost (\$142) for children with obesity was higher than the cost of healthy weight children (\$120), the cost of children with overweight was lower (\$102).[@R22]

Wolfenstetter assessed weight changes over 10 years and the related costs per group and found that the cost of a person with overweight or obesity is higher than the economic loss of a healthy weight or previously healthy weight person.[@R36] Neovius *et al* also applied a longitudinal approach with data from 1969 and a 38-year follow-up. They estimated lifetime productivity losses of \$18 064 using the HCA (FCM: \$12 995) for overweight and \$19390 (FCM: \$14 317) for obesity.[@R21] Another long-term study evaluated the yearly cost of a 20 000 workforce over 30 years at \$6.6 million.[@R28]

### Presenteeism {#s3c2}

Nine studies included the effect of reduced productivity at work (presenteeism) due to overweight or obesity, which was assessed by using an employee survey.[@R31] While costs due to presenteeism among individuals with overweight ranged between −\$611[@R31] and \$1669,[@R33] costs among individuals with obesity were between \$11[@R46] and \$4175.[@R31] Surprisingly, in Peake's study, the cost of presenteeism among employees with overweight (\$474) was lower than for individuals with normal weight (\$695).[@R35] Similarly, Finkelstein *et al* estimated lower costs among men with overweight compared with men with normal weight.[@R31] The excess cost of obesity ranged from \$429 to \$4175 for men and from \$927 to \$3341 for women.[@R31] Another study by Finkelstein *et al* measured the quarterly indirect costs of bariatric surgery patients to be \$11.[@R46] The cost of moderate or extreme obesity was estimated to be \$699,[@R51] \$1684,[@R33] \$1990[@R32] and \$2414.[@R45] Peake and co-authors differentiated between the cost of having a BMI higher than 30 with restricted body fat (≤28% for females, ≤24% for males) (\$1129) and having a BMI higher than 30 without body fat restriction (\$984).[@R35]

One study calculated the combined costs of absenteeism and presenteeism. The combined costs were \$5515 for overweight and from \$6402 to \$9104 for obesity classes I--III.[@R40]

### Insurance claims {#s3c3}

Insurance claims were measured as indemnity claims[@R20] or workers' compensation expenditures due to work absence.[@R16] The only study which exclusively assessed insurance claims estimated indemnity claim costs at \$189 per full-time equivalent.[@R20] For workers' compensation, the additional costs of overweight were estimated to be \$180 and the additional costs for obesity classes I--III ranged from \$525 to \$707.[@R16] Kleinman *et al* assumed the costs of overweight at \$63 and those of obesity at \$105.[@R18]

### Short-term and long-term disability {#s3c4}

Four studies considered costs of lost productivity due to short-term and long-term disability.[@R16] While excess costs due to disability were estimated to range from \$30[@R16] to \$41[@R51] among individuals with overweight, obesity was associated with costs between \$21 and \$439.[@R51] Kleinman *et al* estimated \$158 for overweight and \$242 for obesity.[@R18] The lifetime cost of disability and disability pensions varied substantially depending on methodology; while estimations of cost based on the HCA varied between \$31 037 (overweight) and \$32 668 (obesity), estimations of cost based on the FCM were \$2649 (overweight) and \$3115 (obesity).[@R21]

### Premature mortality {#s3c5}

Work loss due to early mortality was assessed by two studies.[@R21] Excess productivity costs related to these indirect costs were \$29 for overweight and from \$212 to \$1170 for grade I--III obesity.[@R51] Neovius *et al* calculated the lifetime productivity losses and found \$87 184 (HCA) or \$20 066 (FCM) for overweight and \$114 626 (HCA) or \$23 070 (FCM) for obesity.[@R21]

Macroeconomic findings {#s3d}
----------------------

Among the studies focusing on macroeconomic costs, all but two focused on national costs for 1 year and found costs ranging from \$79 million in New Zealand[@R19] to \$41 billion for three US states.[@R48] [Figure 3](#F3){ref-type="fig"} displays the national costs per country and online [supplementary supporting information 5](#SP1){ref-type="supplementary-material"} shows per capita estimates of the macroeconomic findings. Knoll and Hauner estimated that the cost of obesity would increase from \$1.8 billion in 2003 to \$3.6 billion in 2020.[@R49] Lightwood and co-authors estimated future costs in USA on current adolescent obesity and proposed a rise in costs from \$954 million in 2020 to \$36 billion in 2050.[@R45]

![Macroeconomic costs of overweight and obesity. Ricci and Chee,[@R38] Lightwood *et al*[@R45] and Chenoweth and Leutzinger[@R48] are outliers (coloured in grey). \*Costs of the three US states: California, North Carolina, Massachusetts. ^+^Costs of the province Alberta. \*\*Costs of the state New Mexico. ^++^Costs of South Plains of Texas. Almost analogous to country size and high prevalence rates, USA has the highest national costs. Its lower values are related to particular states. The lowest costs were found in 2006 in New Zealand. National costs seem to increase in future years.](bmjopen-2016-014632f03){#F3}

The majority of the PAF studies included costs of absenteeism, disability and premature death (for detailed information, see online [supplementary supporting information 4](#SP1){ref-type="supplementary-material"}). The PAF approach indicates the aetiological fraction of morbidity and mortality of disease prevalence caused by a risk factor (see equation 1):

$$PAF = \frac{\sum\limits_{i = 1}^{n}P_{i}RR_{i} - \sum\limits_{i = 1}^{n}P_{i}^{\prime}RR_{i}}{\sum\limits_{i = 1}^{n}P_{i}RR_{i}}$$

*P~i~*=proportion of population at exposure level *i*, current exposure,

*P\'~i~*=proportion of population at exposure level *i*, counterfactual or ideal level of exposure,

*RR*=the relative risk at exposure level *i*,

n=the number of exposure levels.

More specifically, there is strong evidence for higher risk of comorbidities such as type 2 diabetes, hypertension, coronary heart disease and stroke in individuals with overweight and obesity.[@R55] Since overweight and obesity cause only a fraction of comorbidity-related costs, multiplying the PAF by the costs of each comorbidity and then summing up across all diseases estimates total obesity-attributable costs.

Five studies assessed the costs of excess weight in Germany.[@R4] Lehnert *et al* estimated the costs at \$9.5 billion,[@R4] Konnopka *et al* at \$6.5 billion[@R57], Knoll and Hauner at \$1.8 billion[@R49] and Sander and Bergemann at \$282 million.[@R50] The costs for Canada were suggested to be \$2.7 billion by Katzmaryk and Janssen,[@R58] \$4.4 billion by Anis *et al*[@R59] and \$534 million (for Alberta only) by Moffatt *et al*.[@R60] The economic loss for the Ireland was between \$767 million (FCM) and \$840 million (HCA). For Northern Ireland, the cost was proposed to be between \$294 million (FCM) and \$491 million (HCA).[@R61] In addition to costs of absenteeism and premature death, Lal *et al* assessed training and recruitment costs for New Zealand and suggested a national loss between \$79 million (FCM) and \$180 million (HCA).[@R19] In Korea, the productivity loss of excess weight was proposed to be at \$872 million due to premature death, hospital admission, nursing costs and fees and transportation costs.[@R17] The economic loss associated with excess weight in Australia was estimated to be at \$637 million.[@R62] For three US states (California, North Carolina, Massachusetts), Chenoweth and Leutzinger assumed a productivity loss of \$41 billion.[@R48]

While the majority applied the PAF approach, 12 studies assessed the national costs based on lost workdays due to work absence, loss of productivity and premature death.[@R24] Eight studies assessed the economic loss in USA. The costs for obesity were estimated to be \$11.3 billion by Asay *et al*,[@R66] \$171 million for grade III obesity by Klarenbach *et al*,[@R63] and \$3.8 billion due to non-diabetic and morbidly obese by Cawley *et al*.[@R42] The costs of obesity were assessed at \$5.5 billion[@R52] by Cawley and co-authors and \$9 billion by Andreyeva *et al[@R27]*. Ricci and Chee were the only ones to consider the excess costs of absenteeism and presenteeism in the United States, which they estimated to be \$15.7 billion for obesity. The costs of overweight and normal weight did not differ significantly.[@R40] Two studies focused on the economic loss due to obesity in specific US regions (\$409 million in a region of Texas[@R30] and \$2 billion in the state of New Mexico[@R32]). One study estimated the costs for the province of Quebec in Canada at \$531 million.[@R65] For Germany, the cost of overweight and obesity was \$2.5 billion according to a study by Lehnert *et al[@R37]*, and \$5 billion according to a later study by Effertz *et al*.[@R64] Economic loss due to premature death was estimated for Sweden at \$4.8 million for overweight and \$383 million for obesity.[@R28]

Discussion {#s4}
==========

This review assessed 50 COI studies on the indirect costs of overweight and obesity. The studies applied various methodologies and were mostly of good quality. Although the results varied, most studies found that excess weight entailed substantial indirect costs. While the cost category primarily considered was sick leave, there was also frequent assessment of presenteeism, disability and premature death. Compared with employees with normal weight, individuals with obesity missed more time from work and worked less productively, resulting in higher indirect costs. Even if the literature suggests substantial indirect costs of overweight and obesity, the results should be interpreted with caution.

Our findings identify and underscore the large variety in defining and measuring the indirect costs of overweight and obesity. Indeed, this large variety made it difficult to provide an estimate of these indirect costs. Moreover, these costs differ substantially due to dissimilar methodological approaches (eg, HCA vs FCM) and varying analytic methods (eg, simulation-based vs regression-based models) (see online [supplementary supporting information 4](#SP1){ref-type="supplementary-material"}). This is especially true of excess indirect costs of overweight, which range between −517 US\$PPP[@R31] and 3271 US\$PPP.[@R30] These methodological differences, in turn, hamper the comparability of cost estimations of overweight and obesity.

The heterogeneity of the results raises the question whether the cost estimates correctly reflect the actual indirect costs of overweight and obesity. Most of the included studies used a top-down approach, which is usually easier to carry out as it is based on secondary data and thus requires only few country-specific estimates. However, in contrast to the bottom-up approach, it often relies on high-level aggregation and approximation of service costs and may also suffer from double-counting of resources. Moreover, the top-down approach does not take account of multiple obesity-attributable diseases (eg, type 2 diabetes and coronary heart disease) and their interactions, which may lead to biased (usually upwards) results.[@R67]

Furthermore, the comprehensiveness of costs included in an analysis affects the reliability of the final result. If indirect costs consist of absenteeism costs alone, they will differ from indirect costs due to absenteeism and presenteeism combined. Additional workplace costs, such as transport costs and special training for hospital staff, together with non-monetary costs (eg, quality-of-life losses) were included in a minority of the studies. Differences in indirect costs of overweight and obesity in the workplace can partly be explained by individual incomes. Individual wages (only captured by Kleinman *et al*[@R18]) consider occupation-specific incomes and the fact that women with overweight and men with obesity earn lower wages than normal-weight workers.[@R68] Most of the assessed COI studies calculated indirect costs based on estimations of the income of employees. These heterogeneous estimations of cost may be partly explained by occupation-specific incomes and different wage estimates (range: \$6 per hour[@R63] to \$500 daily wage[@R44]).

Besides costs measured by income in workplace-related productivity losses, costs from unpaid work can occur. In our review, one study examined costs from unpaid work and found that reduced household production activities of caregivers cause sizeable indirect costs comparable with those of paid work.[@R58] Moreover, this cost category is also important as the prevalence of childhood overweight and obesity has increased dramatically during the past few years, confronting (grand)parents and caregivers with time losses from unpaid work. A longer measurement period may influence the accuracy of the assessed costs. Two of the studies reviewed considered the impact of childhood overweight and obesity.[@R22] Lightwood *et al* recorded a long timeframe including indirect costs from adolescence and calculated high indirect costs of excess weight for future years.[@R45]

Finally, the lack of evidence for the causal link between obesity and productivity loss has been noted in previous reviews.[@R5] Recent studies have tried to address this shortcoming by applying longitudinal study designs and controlling for confounding factors, including sociodemographic and work-related and health-related covariates.[@R21] However, all these studies assume that obesity is a direct cause of productivity loss and may thus overestimate the effect on indirect cost. None of them comprehensively address the question, together with associated statistical challenges, whether obesity could also serve as a biological mediator on the causal pathway or an effect modifier. Indeed, obesity may act both as direct explanatory variable and mediator when studying the relationship between cardiorespiratory fitness and productivity loss due to increased metabolic syndrome.[@R70] Additionally, obesity could also serve as an effect modifier as different levels of obesity modify the association between cardiorespiratory fitness and productivity loss. Moreover, the loss of productivity with increasing BMI declines with age as a higher BMI tends to be protective (eg, reduced bone density loss and osteoporosis).[@R71]

Clearly, a causal framework for a meaningful assignment of indirect costs of obesity requires establishing whether obesity acts as a cause, a mediator or an effect modifier. More specifically, prospective analyses are urgently needed to determine the time of occurrence, that is, whether diseases occur before (after) an individual has become overweight or obese. Together with such prospective analyses, valid measurements of productivity losses have to be developed and new studies initiated which measure productivity among employees before and after an effective obesity intervention. Only then can there be a successful application of more sophisticated econometric models.

Overall, most studies met most of the quality criteria but could be improved in three major areas. First, the scope could be increased by including more than one cost category. Second, estimations of cost would be more accurate if they included obesity-related diseases and were based on individual income. Third, the reliability of long-term economic consequences would be improved by taking childhood obesity into account. To translate lifetime consequences of childhood obesity into economic calculations, it is important to develop dynamic models of obesity-related productivity losses projected over a timeframe longer than the 1 year period usually used in cost-of-obesity estimations.[@R73]

One limitation of this review is the potential publication bias, whereby positive studies are more likely to be published than negative studies. For instance, 47 out of the 50 included studies reported higher costs of overweight and obesity. While all studies reported higher costs of obesity, three studies found lower costs of overweight compared with normal weight. Furthermore, due to financial and time restraints, we could only include studies published in English and German, which may result in a selection bias. However, our findings include results from 11 countries and regions which are neither English-speaking nor German-speaking.

The included studies exhibited methodological inconsistencies and varying levels of quality. Nevertheless, they consistently confirm that overweight and obesity have substantial short-term and long-term indirect costs both on the microeconomic and macroeconomic level. Consequently, an increase in public health initiatives, together with effective company weight-loss programmes, could considerably improve the productivity of workers currently overweight or obese.
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